Loud Muscle Science Launch Sequence Aphrodisia Capsules Recall

Why it was recalled

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Product description

Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.

Lot numbers, UPCs & expiration codes

Lot # 2022104, exp. date 04/2025

Where it was sold

The product was distributed nationwide in the USA and Canada.

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-1338-2022
Classification: Class I
Status: Terminated
Recall initiated: Jun 27, 2022
FDA report date: Jul 27, 2022
Quantity: 500 4-count tins
Recall type: Voluntary: Firm initiated
Recalling firm: Loud Muscle Science

Original FDA data

Every field from FDA enforcement report D-1338-2022, exactly as published.

Show all FDA fields

City: Hauppauge
State: NY
Status: Terminated
Country: United States
Event ID: 90551
Address: 300 Oser Ave
Code information: Lot # 2022104, exp. date 04/2025
Postal code: 11788-3608
Report date: Jul 27, 2022
Product type: Drugs
Recall number: D-1338-2022
Classification: Class I
Recalling firm: Loud Muscle Science
Product quantity: 500 4-count tins
Termination date: Feb 8, 2023
Reason for recall: Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Voluntary / mandated: Voluntary: Firm initiated
Product description: Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.
Distribution pattern: The product was distributed nationwide in the USA and Canada.
Recall initiation date: Jun 27, 2022
Initial firm notification: Press Release
Center classification date: Aug 15, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1338-2022, published Jul 27, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.